Who Paid My Doc Search
Menu
Organisation paid for research Program year 2023 Source: CMS Open Payments

Tulsa Retina Consultants

Neither a doctor nor a teaching hospital

Research payments

$664,720

34 payments

Through program year 2023, Tulsa Retina Consultants is reported as receiving $664,720 in research payments, across 34 payments.

By program year

5 rows
Year Kind Amount Payments
2023 Research $178,370 8
2022 Research $207,582 11
2021 Research $264,330 11
2020 Research $9,987 2
2019 Research $4,450 2

Breakdown

Who paid Research payments · program years 2019–2023
  1. Regeneron Pharmaceuticals, Inc. $660,270 32 payments
  2. Alimera Sciences, Inc. $4,450 2 payments
Studies the money was for Research payments · program years 2019–2023
  1. A Randomized, Double-Masked, Active-Controlled Phase 2/3 Study of the Efficacy and Safety of High-Dose Aflibercept in Patients With Diabetic Macular Edema $660,270 32 payments
  2. Paladin $4,450 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record